Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mangoceuticals (MGRX) Revenue (2023 - 2025)

Historic Revenue for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $84246.0.

  • Mangoceuticals' Revenue fell 3683.19% to $84246.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $466908.0, marking a year-over-year decrease of 3815.79%. This contributed to the annual value of $615873.0 for FY2024, which is 1580.6% down from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Revenue is $84246.0, which was down 3683.19% from $168109.0 recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Revenue registered a high of $245160.0 during Q3 2023, and its lowest value of $84246.0 during Q3 2025.
  • In the last 3 years, Mangoceuticals' Revenue had a median value of $141237.0 in 2023 and averaged $155366.1.
  • Data for Mangoceuticals' Revenue shows a peak YoY increase of 11256.03% (in 2024) and a maximum YoY decrease of 5693.2% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Mangoceuticals' Revenue stood at $244374.0 in 2023, then plummeted by 56.93% to $105247.0 in 2024, then dropped by 19.95% to $84246.0 in 2025.
  • Its Revenue was $84246.0 in Q3 2025, compared to $168109.0 in Q2 2025 and $109306.0 in Q1 2025.